149 related articles for article (PubMed ID: 16953148)
1. Gastric precancerous changes: carcinogenesis, clinical behaviour immunophenotype study and surveillance.
Testino G
Panminerva Med; 2006 Jun; 48(2):109-18. PubMed ID: 16953148
[TBL] [Abstract][Full Text] [Related]
2. [Gastric preneoplastic changes].
Testino G
Recenti Prog Med; 2004 May; 95(5):239-44. PubMed ID: 15202673
[TBL] [Abstract][Full Text] [Related]
3. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
[TBL] [Abstract][Full Text] [Related]
4. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
5. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
6. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection.
de Vries AC; Haringsma J; Kuipers EJ
Helicobacter; 2007 Feb; 12(1):1-15. PubMed ID: 17241295
[TBL] [Abstract][Full Text] [Related]
7. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and gastric cancer.
Matysiak-Budnik T; Mégraud F
Eur J Cancer; 2006 Apr; 42(6):708-16. PubMed ID: 16556496
[TBL] [Abstract][Full Text] [Related]
9. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia.
Egi Y; Ito M; Tanaka S; Imagawa S; Takata S; Yoshihara M; Haruma K; Chayama K
Jpn J Clin Oncol; 2007 May; 37(5):365-9. PubMed ID: 17578895
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway.
Farinati F; Cardin R; Cassaro M; Bortolami M; Nitti D; Tieppo C; Zaninotto G; Rugge M
Eur J Cancer Prev; 2008 Jun; 17(3):195-200. PubMed ID: 18414189
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
12. [Helicobacter pylori and gastric carcinogenesis].
Testino G; Testino R; Ancarani AO
Recenti Prog Med; 2001 Oct; 92(10):573-7. PubMed ID: 11695299
[TBL] [Abstract][Full Text] [Related]
13. Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
De Vries AC; Kuipers EJ
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():25-35. PubMed ID: 18081646
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of gastric cancer: an evaluation of available evidence.
Palli D
J Gastroenterol; 2000; 35 Suppl 12():84-9. PubMed ID: 10779225
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
[TBL] [Abstract][Full Text] [Related]
17. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
[TBL] [Abstract][Full Text] [Related]
18. [Gastric cancer and Helicobacter pylori: an interdisciplinary point of view].
Pellicano R; Mladenova I; Martinotti R; Fagoonee S; Rizzetto M
Minerva Med; 2006 Feb; 97(1):31-8. PubMed ID: 16565696
[TBL] [Abstract][Full Text] [Related]
19. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
[TBL] [Abstract][Full Text] [Related]
20. Risk factors in gastric cancer.
Compare D; Rocco A; Nardone G
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):302-8. PubMed ID: 20496539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
